Story thread · 4 reports / 4 sources
Sandoz CEO Views Trump’s Generics Tariff Threat as Opportunity
bloomberg.com · 6d
How the coverage leans
Across 4 sources · syndicated copies counted once
Sandoz Group AG Chief Executive Officer Richard Saynor said the move by US President Donald Trump to potentially impose tariffs on generic medicines is more of an opportunity than a threat to its business.
First report: Sandoz agrees $450 million settlement with 43 US states over antitrust claims — investing.com, 8d
The coverage
- NH joins $469M multistate settlement with generic drug maker Sandoz over price-fixing claims
unionleader.com · 8d
- Sandoz in $450M settlement over 43 US states' antitrust claims
seekingalpha.com · 8d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.